Lithium carbonate Prescribing at MAPLE ACCESS PARTNERSHIP LLP
Drugs used in psychoses and related disorders | Central Nervous System
Items (12m)
208
Total Quantity
3,827
NHS Cost
£2.4K
vs National Avg
+64%
MAPLE ACCESS PARTNERSHIP LLP prescribed 208 items of Lithium carbonate over the last 12 months at a cost of £2,378 to the NHS. This is 64% above the national average prescribing rate. Lithium carbonate is classified under Drugs used in psychoses and related disorders in the BNF.
Monthly Prescribing Trend
Jun 2026
15
Jun 2026
13
Jun 2026
20
Jun 2026
14
Jun 2026
14
Jun 2026
20
Jun 2026
18
Jun 2026
21
Jun 2026
19
Jun 2026
15
Jun 2026
21
Jun 2026
18
Prescribing Details
| Total Items | 208 |
|---|---|
| Total Quantity | 3,827 |
| Total NHS Cost | £2,378 |
| Presentations | 3 different forms |
| vs National Average | +64% |
Lithium carbonate Prescribing Comparison
| This practice | 208 items |
|---|---|
| National average per practice | 127 items |
| Difference | +64% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.